Literature DB >> 31068756

The Myocardial Bridge: Potential Influences on the Coronary Artery Vasculature.

Hiroki Teragawa1, Chikage Oshita1, Tomohiro Ueda1.   

Abstract

A myocardial bridge (MB) is an anatomical abnormality of the coronary artery and is characterized by the systolic narrowing of the epicardial coronary artery caused by myocardial compression during systole. An MB is frequently observed on cardiac computed tomography or coronary angiography and generally appears to be harmless in the majority of patients. However, the presence of MB is reportedly associated with abnormalities of the cardiovascular system, including coronary artery diseases, arrhythmia, certain types of cardiomyopathy, and cardiac death, indicating that MB serves a pivotal role in the occurrence and/or development of such cardiovascular events. Recently, there has been an increasing interest in the coexistence of MB and coronary spasm in research due to opposing aspects regarding their treatments. For example, monotherapy using β-blockers, which are effective in patients with MB, may worsen symptoms in patients with coronary spasm. By contrast, nitroglycerin, which is an effective treatment option for coronary spasm, may worsen symptoms in patients with MB. This review focuses on the pathophysiology and diagnosis of MB and MB-related cardiovascular diseases, including coronary spasm, and on the treatment strategies for MB.

Entities:  

Keywords:  coronary spasm; exertional angina; myocardial bridge; rest angina; vasospastic angina

Year:  2019        PMID: 31068756      PMCID: PMC6495429          DOI: 10.1177/1179546819846493

Source DB:  PubMed          Journal:  Clin Med Insights Cardiol        ISSN: 1179-5468


Introduction

Coronary arteries are normally distributed over the epicardial surface of the heart; however, they occasionally run a segmental intramyocardial course. In such cases, this segment of the vessel is compressed during systole, a condition referred to as milking or a systolic myocardial bridge (MB).[1-6] As coronary blood flow occurs primarily during diastole, this phenomenon appears to be harmless and does not significantly influence the myocardium in the majority of patients with MB.[7] However, there have been cases for which MB has been reported as the cause of ischemic heart diseases, such as exertional angina, vasospastic angina, acute myocardial infarction, and sudden cardiac death.[8-16] These findings have prompted significant research interest on the association between MB and coronary artery diseases, including not only coronary atherosclerosis but also coronary spasm.[17-20] The present review focuses on the pathophysiology and diagnosis of MB and MB-related cardiovascular diseases, with particular emphasis on coronary spasm and treatment strategies for MB.

Pathophysiology and Prevalence of MB

The 2 main pathological findings of MB from autopsy and intravascular ultrasound (IVUS) are the absence of atherosclerosis at the intramural and distal segments of the MB, and the presence of developing atherosclerosis at the proximal segment of the MB.[21-24] MB-related biomechanical forces may account for these findings.[5,25] Systolic milking of the MB disturbs blood flow and may lead to the development of atherosclerosis at the entrance of the MB.[26] Systolic compression of the coronary artery by an MB itself,[27] in addition to the presence of atherosclerosis, may account for myocardial ischemia during exercise. In addition, autopsy findings have revealed that the systolic compression of an MB may lead to plaque rupture at atherosclerotic lesions proximal to the MB segments[28] and that this possible mechanism may account for the occurrence of MB-related acute coronary syndrome (ACS). By contrast, several studies have reported abnormal vasoreactivity at the MB segments.[17,18,29] Reportedly, turbulent flow may increase endothelial cell apoptosis or tumor necrosis factor-α–induced endothelial cell activation, whereas a steady laminar flow leads to the inhibition of endothelial cell apoptosis or tumor necrosis factor-α–induced endothelial cell activation.[30] These factors may cause vascular dysfunction; therefore, turbulent shear stress secondary to the milking of MB segments may contribute to MB-induced vascular dysfunction. The abnormal vasoreactivity of the coronary artery at the MB segments may cause coronary spasm.[17-20] A recent study using optical coherence tomography (OCT) revealed that the adventitial vasa vasorum (VV), which serves a significant role in the morphological and functional changes of the coronary vasculature, was clearly noted at the proximal and distal segments of the MB, whereas the adventitial VV was less frequently observed within the MB segments.[31] As the increase in adventitial VV was associated with coronary spasm,[32] these findings may also contribute to the occurrence of MB-related coronary spasm. The prevalence of MB depends on the modalities of evaluation and the patients in question. In addition, it is established that the use of nitroglycerin (NTG) augments the degree of MB[23,33] and that this may influence the prevalence of MB. The frequency of MB varies between 5.4% and 80% of autopsy cases,[34-36] between 25% and 30.2% of cases assessed using cardiac computed tomography (CT),[37-39] and between 0.5% and 16.0% of cases assessed using coronary angiography.[1,3-5] According to the results of a recent meta-analysis of the prevalence of MB,[40] the overall prevalence was 19%; autopsy studies revealed an overall prevalence of 42%, CT studies 22%, and coronary angiography 6%. The location of MB was primarily observed in the left anterior descending artery (LAD) in 67% to 98% of cases[5,39-41] although MB was also detected in the left circumflex coronary artery and right coronary artery.

MB Diagnosis

There are several modalities used in the diagnosis of MB, including noninvasive and invasive types. The noninvasive modality for diagnosing MB is cardiac CT,[37-39] which is reported to be superior to CAG in terms of detection sensitivity.[40] Furthermore, cardiac CT can easily assess the length and thickness of MB over the coronary artery.[42] Exercise echocardiography has recently been reported as an effective noninvasive modality for assessing MB; this method cannot assess or identify the presence of MB but can suggest the presence of MB by revealing the specific characteristic of focal buckling of the septum with apical sparing during the end-systolic and early-diastolic phases.[43,44] By contrast, echocardiography, particularly, more advanced echocardiography, may be useful for the noninvasive assessment of the hemodynamic significance of MB.[45] The invasive modality for diagnosing MB is CAG. A significant “milking effect” is present when there is ⩾70% reduction in minimal luminal diameter during systole and persistent ⩾35% reduction in minimal luminal diameter during mid-to-late diastole.[3,5] As previously described, the use of NTG augments the severity of the compression caused by an MB.[23,33] Therefore, NTG should be administered immediately prior to the CAG assessment of MB if hemodynamics are stable. Furthermore, as MB is primarily present at the midterm of the LAD,[40] a straight cranial view may be desirable in the assessment of MB. There are several modalities for the evaluation of MB, in addition to CAG, which include IVUS,[22,23,25,46,47] OCT,[48,49] Doppler flow wire,[22,50] and pressure wire.[5,50,51] Using IVUS, the characteristic finding is a “half-moon” sign, an echolucent area present only between the MB segment and the epicardial tissue that persists throughout the cardiac cycle.[22] OCT is also a useful modality for assessing the presence of MB.[48,49] A previous study reported that the MB length was longer and the degree of MB was smaller when assessed using OCT compared with that when assessed using CAG.[49] Such morphological assessments using IVUS and OCT can detect and assess the presence of atherosclerosis or intimal thickening proximal to the MB.[5,47] By contrast, the Doppler flow wire and pressure wire methods can assess MB both physiologically and functionally.[22,50,51] Using a Doppler flow wire, a characteristic velocity pattern termed the “fingertip” phenomenon is observed at the MB segments, exhibiting an abrupt early-diastolic acceleration, rapid middiastolic deceleration, and a mid-to-late diastolic plateau. Pharmacological stress intracoronary pressure using a pressure wire is useful when assessing the presence of myocardial ischemia or a significant MB, rather than the presence of the MB itself.[5,50,51] In the physiological assessment of organic stenosis, the fractional flow reserve (FFR) has been widely used in the clinical setting using a pressure wire and intravenous adenosine. This method is also useful for the assessment of MB. A patient with MB and an FFR of <0.75 is likely to have MB-related myocardial ischemia.[5] However, intravenous dobutamine may be more useful in the assessment of significant MB as it can increase the strength of myocardial contraction and subsequent compression of the coronary artery at MB segments.[5,51] This method is of most value when an FFR with intravenous adenosine is considered nonsignificant. However, this method involving intravenous dobutamine stress is accompanied by complications and can be time-consuming. Recent reports highlight that FFR using hand-grip stress[52] or instantaneous wave-free ratio (iFR)[53] are useful in assessing myocardial ischemia in a patient with MB. In terms of the latter,[53] it has been reported that iFR is more consistent with patients’ symptoms than FFR. Physiological assessment using iFR is desirable in the near future.

Influences of MB on the Cardiovascular System

The influence of MB on the coronary vasculature includes the following effects (Figure 1): (1) myocardial ischemia due to the presence of mechanical compression of the coronary artery induced by systolic milking of MB or the coexistence of mechanical compression and atherosclerotic changes proximal to the MB segments;[22] (2) development of ACS with thrombus formation, in part, due to plaque rupture induced by vascular compression at the atherosclerotic lesion proximal to the MB segments;[24,28] and (3) coronary spasm (Figure 2).[17-20] The presence of myocardial ischemia due to mechanical compression of an MB and atherosclerotic lesion proximal to the MB has been described in numerous studies.[5,51,54,55] MB-related ACS may be due, at least in part, to plaque rupture induced by mechanical compression.[24,28] However, spontaneous coronary dissection induced by MB[56] or coronary spasm at the MB segments[57,58] may also account for the development of ACS.[59] The association between MB and coronary spasm has become a focus of increasing research interest (Table 1).[17-20] Our previous study demonstrated that MB was one of the factors associated with the presence of coronary spasm.[17] Kim et al[18] also showed that the vasoconstrictive response was higher at the MB segments. In addition, Saito et al showed that a morphologically severe (longer) MB and a higher percentage of systolic compression were associated with MB-induced coronary spasm in the LAD.[19] Nam et al also reported that the presence of MB is associated with the occurrence of coronary spasm and that patients with MB and coronary spasm have a higher rate of recurrent angina.[20] Among these four studies,[17-20] coronary spasm always occurred at the location of the MB, although another coronary spasm occurred at other locations and/or other vessels. Collectively, these data may provide evidence for an association between MB and coronary spasm. In addition, it has been reported that the length of MB is the important factor responsible for MB-related coronary spasm[19,20] and that the presence of MB was associated with recurrent angina.[20] It has previously been considered that coronary spasm occurs more frequently in Asians than in Caucasians;[60] however, a recent study showed that the incidence of coronary spasm was similar between Asians and Caucasians.[61-63] Furthermore, coronary spasm is the cause of not only rest angina but also exertional angina.[64-68] Therefore, worldwide, increased attention on MB-related coronary spasm is required in patients with MB experiencing chest symptoms at rest and during exertion, as the treatments for MB and MB-related coronary spasm are different.
Figure 1.

Possible mechanisms of the development of the myocardial bridge responsible for coronary artery disease, and favorable treatments based on the causes.

CAD indicates coronary artery disease; CCB, calcium channel blocker.

Figure 2.

Coronary angiograms in a representative patient with myocardial bridge (MB) and coronary spasm. The patient experienced chest symptoms during exercise in the early morning only. Coronary angiography revealed a severe vasospasm provoked by intracoronary infusions of acetylcholine (indicated by arrows) (A) and the presence of MB at spastic segment (B: diastole, C: systole), which is indicated by arrows.

MB indicates myocardial bridge.

Table 1.

Studies showing the relationship between MB and coronary spasm.

No.AuthorsReference No.YearMain findings
1Teragawa et al162003In 114 patients who had any chest symptoms, MB was one of predictors of presence of coronary spasm, on logistic regression analysis. In addition, the MB segment in response to acetylcholine was more constrictive, even in patients without coronary spasm.
2Kim et al172008In 128 patients with typical angiographic MB, coronary vasoconstriction (>50%) to acetylcholine was observed more often than control patients (89.1% vs 35.1%), despite the absence of plaque at the MB segments on intravascular ultrasonographic study.
3Saito et al182017In 392 patients who underwent spasm provocation test, LAD spasm was provoked more frequently in patients with MB. Multivariate regression analysis demonstrated that the length of MB and percent systolic compression of MB were significant predictors for provoked LAD spasm.
4Nam et al192018In 812 patients with MB, coronary spasm was provoked in 59.1% of patients. The length of MB, percent systolic compression of MB, and reference diameter were associated with coronary spasm. Patients with MB and coronary spasm experienced recurrent angina more frequently during the 5-year follow-up.

Abbreviations: LAD, left anterior descending coronary artery; MB, myocardial bridge.

Possible mechanisms of the development of the myocardial bridge responsible for coronary artery disease, and favorable treatments based on the causes. CAD indicates coronary artery disease; CCB, calcium channel blocker. Coronary angiograms in a representative patient with myocardial bridge (MB) and coronary spasm. The patient experienced chest symptoms during exercise in the early morning only. Coronary angiography revealed a severe vasospasm provoked by intracoronary infusions of acetylcholine (indicated by arrows) (A) and the presence of MB at spastic segment (B: diastole, C: systole), which is indicated by arrows. MB indicates myocardial bridge. Studies showing the relationship between MB and coronary spasm. Abbreviations: LAD, left anterior descending coronary artery; MB, myocardial bridge. MB is reportedly associated with several types of cardiomyopathy[69-73] or arrhythmia.[74-76] MB-induced focal myocardial ischemia may account for the prognosis of hypertrophic cardiomyopathy[69] and the development and prognosis of takotsubo cardiomyopathy.[71-73] In terms of the association between MB and arrhythmia, exercise-induced QT dispersion has been shown to be increased in patients with MB, which suggests that MB-induced focal myocardial ischemia leads to arrhythmia.[74-76]

Treatment for Symptomatic MB

Pharmacological treatment is recommended as first-line therapy for patients with symptomatic MB. Nonpharmacological invasive treatments for symptomatic MB include percutaneous coronary intervention (PCI),[5,77-79] coronary artery bypass grafting (CABG), and/or surgical unroofing.[5,80-83] However, the results of these nonpharmacological treatments, with the exception of surgical unroofing,[82,83] have not been satisfactory.[5,77-79,81] In terms of surgical unroofing, which is either performed with or without CABG, the procedure may be promising in symptomatic patients with MB who are refractory to medical therapies,[82,83] and further information on surgical unroofing is required. When administering these medications, attention to patient symptoms at rest and during exercise is required. The cause of symptoms during exercise is considered to be the mechanical compression of the coronary artery of MB, with the administration of β-blockers recommended as first-line therapy. However, the administration of β-blockers alone may worsen chest symptoms in patients with symptomatic MB and coronary spasm. Prior to the administration of β-blockers, it is important that the possibility of worsening chest symptoms be explained to patients (Figure 1).[14,68] Therefore, the administration of pharmacological treatments requires strict control. If patients under optimal medical therapy experience life-restricting symptoms, then the consideration of nonpharmacological treatments, including PCI, CABG, and surgical unroofing, is required.

Conclusions

MB is an anatomical abnormality of the coronary artery, which runs on a segmental intramyocardial course. This abnormality is frequently observed, and the majority of patients with MB may be asymptomatic. However, this abnormality undoubtedly causes myocardial ischemia owing to the coexistence of mechanical compression of the MB and atherosclerotic changes proximal to the MB, which is likely to be the cause of coronary spasm in certain patients. Caution is required when taking both pathologies into account in determining the optimal medical therapy for symptomatic MB.
  82 in total

1.  New signs characteristic of myocardial bridging demonstrated by intracoronary ultrasound and Doppler.

Authors:  J Ge; A Jeremias; A Rupp; M Abels; D Baumgart; F Liu; M Haude; G Görge; C von Birgelen; S Sack; R Erbel
Journal:  Eur Heart J       Date:  1999-12       Impact factor: 29.983

Review 2.  Coronary anomalies: incidence, pathophysiology, and clinical relevance.

Authors:  Paolo Angelini; José Antonio Velasco; Scott Flamm
Journal:  Circulation       Date:  2002-05-21       Impact factor: 29.690

Review 3.  Update on myocardial bridging.

Authors:  Stefan Möhlenkamp; Waldemar Hort; Junbo Ge; Raimund Erbel
Journal:  Circulation       Date:  2002-11-12       Impact factor: 29.690

4.  Acute myocardial infarction associated with myocardial bridge and coronary artery vasospasm.

Authors:  M Sakuma; H Kamishirado; T Inoue; M Ichihara; K Takayanagi; T Hayashi; S Morooka
Journal:  Int J Clin Pract       Date:  2002-11       Impact factor: 2.503

Review 5.  Endothelial atheroprotective and anti-inflammatory mechanisms.

Authors:  B C Berk; J I Abe; W Min; J Surapisitchat; C Yan
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

6.  Augmentation of vessel squeezing at coronary-myocardial bridge by nitroglycerin: study by quantitative coronary angiography and intravascular ultrasound.

Authors:  Y Hongo; H Tada; K Ito; Y Yasumura; K Miyatake; M Yamagishi
Journal:  Am Heart J       Date:  1999-08       Impact factor: 4.749

7.  Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients.

Authors:  J F Beltrame; S Sasayama; A Maseri
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

8.  Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease.

Authors:  S A Mohiddin; D Begley; J Shih; L Fananapazir
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

9.  Dipyridamole TI-201 SPECT imaging in patients with myocardial bridging

Authors: 
Journal:  Clin Nucl Med       Date:  1999-10       Impact factor: 7.794

Review 10.  Symptomatic myocardial bridges: overview of ischemic mechanisms and current diagnostic and treatment strategies.

Authors:  Martial G Bourassa; Ady Butnaru; Jacques Lespérance; Jean-Claude Tardif
Journal:  J Am Coll Cardiol       Date:  2003-02-05       Impact factor: 24.094

View more
  11 in total

1.  Prognostic impact of nitrate therapy in patients with myocardial bridge and coexisting coronary artery spasm.

Authors:  Ji Bak Kim; Byoung Geol Choi; Seung-Woon Rha
Journal:  Heart Vessels       Date:  2022-09-13       Impact factor: 1.814

2.  A Case of Symptomatic Myocardial Bridge Treated with Calcium Channel Blocker.

Authors:  Arash Nemat; Atiqullah Majeedi; Abdul Wahed Sediqi; Qingchun Zeng
Journal:  Int Med Case Rep J       Date:  2022-05-31

3.  Evaluation of intracoronary function after reduction of ventricular rate by esmolol in severe stenotic myocardial bridge: A case report.

Authors:  Long-Jun Sun; Ding-Guang Yan; Shu-Wei Huang
Journal:  World J Clin Cases       Date:  2022-04-26       Impact factor: 1.534

4.  Evaluation of histopathological findings of cardiac deaths in forensic autopsies.

Authors:  Taner Daş; Aytül Buğra; Abdul Kerim Buğra
Journal:  Ir J Med Sci       Date:  2021-05-10       Impact factor: 1.568

5.  Vasospastic angina on coronary angiography.

Authors:  Michael Chahin; Dominika M Zoltowska; Bashar Al-Turk; Siva Suryadevara
Journal:  BMJ Case Rep       Date:  2020-09-06

6.  The Significance of Recognizing Myocardial Bridge in the Coronary Spasm Diagnosis in Myocardial Infarction with Nonobstructive Coronary Arteries.

Authors:  Hiroki Teragawa; Chikage Oshita; Tomohiro Ueda
Journal:  Intern Med       Date:  2019-09-03       Impact factor: 1.271

7.  Coronary Microvascular Vasodilatory Function: Related Clinical Features and Differences According to the Different Coronary Arteries and Types of Coronary Spasm.

Authors:  Hiroki Teragawa; Chikage Oshita; Yuko Uchimura; Ryota Akazawa; Yuichi Orita
Journal:  J Clin Med       Date:  2021-12-27       Impact factor: 4.241

8.  Clinical Characteristics and Prognosis of Patients with Multi-Vessel Coronary Spasm in Comparison with Those in Patients with Single-Vessel Coronary Spasm.

Authors:  Hiroki Teragawa; Chikage Oshita; Yuko Uchimura
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-28

9.  Impact of Myocardial Bridge on Life-Threatening Ventricular Arrhythmia in Patients With Implantable Cardioverter Defibrillator.

Authors:  Kozo Okada; Kiyoshi Hibi; Yutaka Ogino; Nobuhiko Maejima; Shinnosuke Kikuchi; Hidekuni Kirigaya; Jin Kirigaya; Ryosuke Sato; Hidefumi Nakahashi; Yugo Minamimoto; Yuichiro Kimura; Eiichi Akiyama; Yasushi Matsuzawa; Noriaki Iwahashi; Masami Kosuge; Toshiaki Ebina; Kouichi Tamura; Kazuo Kimura
Journal:  J Am Heart Assoc       Date:  2020-10-23       Impact factor: 5.501

Review 10.  Managing Ischemic Heart Disease in Women: Role of a Women's Heart Center.

Authors:  Abha Khandelwal; May Bakir; Meghan Bezaire; Briana Costello; Joanne Michelle D Gomez; Valerie Hoover; Noreen T Nazir; Katherine Nichols; Amy Reisenberg; Anupama Rao; Rupa Sanghani; Melissa Tracy; Annabelle Santos Volgman
Journal:  Curr Atheroscler Rep       Date:  2021-08-04       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.